Medicine Classification




NEW ZEALAND GAZETTE, No. 71 — 11 AUGUST 2016

Fasoracetam (and its stereoisomers)
Felbamate
Flunarizine
Fomepizole
Fonturacetam (and its stereoisomers)
Grazoprevir
Growth Hormone Releasing Hormones
Growth Hormone Releasing Peptide-6
Growth Hormone Releasing Peptides
Idarucizumab
Idebenone
Idelalisib
Imuracetam

Influenza vaccine; except when administered to a person 13 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

Ketoprofen; except when specified elsewhere in this notice
Lesinurad
Levomilnacipran

Methylhexanamine (1,3-dimethylamylamine (DMAA)); except when present as an unmodified, naturally occurring substance
Milnacipran
Molracetam
Naloxegol
Nebracetam (and its stereoisomers)
Nefiracetam
Nepidermin
Netupitant
Nicoracetam
Nitazoxanide
Nivolumab
Noopept (and its stereoisomers)
Otilonium bromide
Oxiracetam (and its stereoisomers)
Paritaprevir
Peginterferon beta-1a
Pembrolizumab
Pentostatin
Picibanil
Piperacetam
Pirfenidone
Ponatinib
Pralmorelin
Pramiracetam

Ranitidine; except when specified elsewhere in this schedule; except in medicines containing 300 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than seven days’ supply

Ranolazine

129



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 71





✨ LLM interpretation of page content

🏥 Classification of Medicines (continued from previous page)

🏥 Health & Social Welfare
Medicines, Classification, Prescription Medicines, Restricted Medicines